TipRanks
Advertisement
Advertisement

ALT Stock Latest News

Altimmune management to meet with Truist
The FlyAltimmune management to meet with Truist
13d ago
ALT
Altimmune Appoints Richard Menziuso as Principal Accounting Officer
PremiumCompany Announcements
Altimmune Appoints Richard Menziuso as Principal Accounting Officer
22d ago
8K
ALT
Altimmune’s Phase 3 MASH Trial Puts Pemvidutide in the Spotlight for Investors
PremiumCompany Announcements
Altimmune’s Phase 3 MASH Trial Puts Pemvidutide in the Spotlight for Investors
28d ago
ALT
Altimmune price target lowered to $17 from $18 at Evercore ISI
PremiumThe Fly
Altimmune price target lowered to $17 from $18 at Evercore ISI
28d ago
ALT
3 Under $10 Stocks With 150%+ Upside to Buy in September 2026, According to Analysts
PremiumMarket News
3 Under $10 Stocks With 150%+ Upside to Buy in September 2026, According to Analysts
2M ago
ALT
KDK
Altimmune Charts Long Runway with Bold Trial Push
PremiumCompany AnnouncementsAltimmune Charts Long Runway with Bold Trial Push
2M ago
ALT
Altimmune Maintained at Buy as Late-Stage Liver Programs Advance and $20 Price Target Remains Unchanged
Premium
Ratings
Altimmune Maintained at Buy as Late-Stage Liver Programs Advance and $20 Price Target Remains Unchanged
2M ago
ALT
Altimmune reports Q2 EPS (12c), consensus (12c)
Premium
The Fly
Altimmune reports Q2 EPS (12c), consensus (12c)
2M ago
ALT
Marathon, Phillips 66, Clean Energy Fuels, Altimmune, Eaton Insider Shake‑Up
PremiumWeekend Updates
Marathon, Phillips 66, Clean Energy Fuels, Altimmune, Eaton Insider Shake‑Up
2M ago
ALT
ETN
Is ALT a Buy, Before Earnings?
PremiumPre-Earnings
Is ALT a Buy, Before Earnings?
2M ago
ALT
ALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
ALT
Altimmune initiates PERFORMA trial
PremiumThe Fly
Altimmune initiates PERFORMA trial
3M ago
ALT
Altimmune’s RECLAIM Study Adds an Addiction Angle to Its Obesity Drug
PremiumCompany AnnouncementsAltimmune’s RECLAIM Study Adds an Addiction Angle to Its Obesity Drug
3M ago
ALT
Barclays says trial data highlights meaningful opportunity for Altimmune in AUD
Premium
The Fly
Barclays says trial data highlights meaningful opportunity for Altimmune in AUD
3M ago
ALT
H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune
Premium
The Fly
H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune
3M ago
ALT
Leerink remains bullish on Altimmune following ‘positive’ AUD trial results
PremiumThe Fly
Leerink remains bullish on Altimmune following ‘positive’ AUD trial results
3M ago
ALT
Unusually active option classes on open July 28th
PremiumThe Fly
Unusually active option classes on open July 28th
3M ago
ALT
HTZ
Altimmune Reports Positive Phase 2 Data in AUD
PremiumCompany Announcements
Altimmune Reports Positive Phase 2 Data in AUD
3M ago
8K
ALT
Altimmune announces RECLAIM trial met primary endpoint
PremiumThe Fly
Altimmune announces RECLAIM trial met primary endpoint
3M ago
ALT
BWXT, Altimmune, Global Payments, AbbVie, Nike Trending With Analysts
PremiumWeekend UpdatesBWXT, Altimmune, Global Payments, AbbVie, Nike Trending With Analysts
4M ago
ALT
GPN
Unusually active option classes on open June 24th
Premium
The Fly
Unusually active option classes on open June 24th
4M ago
BP
ALT
Altimmune initiated with an Outperform at Leerink
Premium
The Fly
Altimmune initiated with an Outperform at Leerink
4M ago
ALT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >